Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Octagon Therapeutics announced it raised $11 Million in an initial filing from an offering of $12.4 Million

PRIVATEFeb 12, 2024•over 2 years ago

Amount Raised

$11 Million

Round Type

Venture - Series Unknown

ProvidenceHealthcare

Company Information

Company

Octagon Therapeutics

Location

225 DYER ST.

Providence, Rhode Island, United States

About

Octagon is developing new medicines for autoimmune and inflammatory disease. The company is pioneering a selective immunomodulation approach based on glyco-immune checkpoint receptors that allows for precise targeting of disease-driving immune processes.

Don't miss Octagon Therapeutics's next move

Get an email the moment Octagon Therapeutics raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
1 contact
Verified contacts9 people are listed at Octagon Therapeutics. We don't have their email yet.
Predictive Intelligence
Strategic

ML-powered predictions for Octagon Therapeutics's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Octagon Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.